What is EarliTec Diagnostics?
EarliTec Diagnostics is at the forefront of revolutionizing autism assessment with its proprietary tool, EarliPoint. This scientifically validated platform empowers clinicians to conduct early, objective, and reliable autism evaluations. By providing faster, more informed decision-making and care planning, EarliTec Diagnostics aims to significantly improve outcomes for families and providers navigating the complexities of autism diagnosis.
How much funding has EarliTec Diagnostics raised?
EarliTec Diagnostics has raised a total of $41M across 2 funding rounds:
Series A
$19.5M
Series B
$21.5M
Series A (2022): $19.5M with participation from Georgia Research Alliance and Bernie Marcus
Series B (2024): $21.5M led by Venture Investors
Key Investors in EarliTec Diagnostics
Venture Investors
Venture Investors Health Fund is a venture capital firm dedicated to advancing healthcare innovations, with a focus on transformative solutions that improve patient lives. Their investment in EarliTec Diagnostics highlights their commitment to early-stage health technology.
Georgia Research Alliance
The Georgia Research Alliance (GRA) is an organization focused on fostering university research and entrepreneurship, supporting the growth of technology and healthcare startups within Georgia. Their participation in EarliTec's funding round signifies support for innovative medical advancements.
Bernie Marcus
Bernie Marcus, a notable figure in business and philanthropy, has invested in EarliTec Diagnostics, indicating a belief in the company's mission to improve early autism assessment and care.
What's next for EarliTec Diagnostics?
The recent major enterprise-level funding, characterized as a strategic investment, positions EarliTec Diagnostics for accelerated growth and market expansion. This capital infusion is expected to fuel further development of its diagnostic tools, enhance its commercial reach, and solidify its position as a leader in early autism assessment. The company is poised to leverage this financial backing to scale its operations and deepen its impact on the healthcare landscape, enabling more timely and accurate diagnoses for children.
See full EarliTec Diagnostics company page
